[68Ga]3BP-3775

N/A

Report date: 2025/11/20 16:04:55

NME

Base Information

Drug Name[68Ga]3BP-3775

Drug Alias Name[68Ga]3BP-377568Ga-3BP-3775

ClassificationDiagnostic agent (In vivo) > Radionuclide Imaging agentRadiation-emitting products > Nuclides > Gallium > 68GaRadiation-emitting products > Radioactive diagnostic agent +[5]

Mechanisms of ActionGlucose-Dependent Insulinotropic Polypeptide Receptor modulators

TargetsGlucose-Dependent Insulinotropic Polypeptide Receptor

Therapy Area/IndicationsNeuroendocrine Tumors

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryGermany

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator Companies3B Pharmaceuticals GmbH

China Registration ClassN/A

Develop Information

Active Companies3B Pharmaceuticals GmbH

Inactive CompaniesN/A

Active IndicationsNeuroendocrine Tumors

Inactive IndicationsN/A

Other Information

ATC CodeN/A